- Genetron Health develops detection kit for COVID-19
- West names Stewart Campbell VP& GM for APAC Region
- Australia to use intravenous zinc in COVID-19 fight
- Sesderma Labs produces Lactyferrin to counter the COVID-19 strain
- Australia offers financial aid to early phase clinical trials in APAC
- Takeda and CSL Behring to Develop Potential COVID-19 Hyperimmune Therapy
- Korean firm invests $2M in SuperTrans Medical
- Chugai starts Ph III trial of Actemra for COVID-19 pneumonia
- Inspirata offers Free Remote Pathology Solution to tackle COVID-19
- Taiwan's Academia Sinica identifies potential COVID-19 inhibitors
- Bio-Rad launches serology assay to detect COVID-19 Abs
- Global Leaders issue G20 call to take action for COVID-19
- Singapore expands 3rd APAC HPC-AI competition to address COVID-19
- Prolong usage of PPE induces headaches in Frontline healthcare workers
-
World | 20 March 2020 | Influencers
Eppendorf is investing disproportionately in expansion of its global locations, particularly in Asia
Congratulations on your new role. What are the main agendas behind the recently announced dual leadership at E...Read more
-
Japan | 10 April 2020 | News
Chugai starts Ph III trial of Actemra for COVID-19 pneumonia
Japan based Chugai Pharmaceutical Co., Ltd. has announced that it is working to start a Phase III clinical tri...Read more
-
Australia | 10 April 2020 | News
Australia to use intravenous zinc in COVID-19 fight
A world-first trial will see researchers from Australia's Austin Health and the University of Melbourne,&...Read more
-
World | 05 March 2020 | News
FDA bans ESDs for self injurious behaviour
After careful consideration, the U.S. Food and Drug Administration (FDA) has published a final rule to ban ele...Read more
-
Europe | 06 March 2020 | News
Viroclinics Biosciences and DDL Diagnostic Lab join forces
Netherlands based Viroclinics Biosciences, a leading virology contract research organization, has announced th...Read more
80 + trails underway to treat COVID-19
In just over 90 days of identification of a pneumonia of unknown cause, the novel coronavirus pandemic, which is raging around the world and posing a challenge for all countries and regions. As on April 2,2020 the number of confirmed COVID-19 cases worldwide has risen above 1 million, according to the new tally fromJohns Hopkins University. Since the emergence of the novel coronavirus (COVID-19 ) biopharmaceutical companies across the world have stepped up their research efforts to develop vaccines and treatments in order to contain the virus. As of March 26, 2020, there are a number of therapeutics currently in clinical trials and more than 52 candidate vaccines are in preclinical evaluation for COVID-19 and 2 candidate vaccines are in clinical evaluation. Over 80 clinical trials are underway to test new and existing medicines across the globe.
